Haslett PA - Search Results

1

Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.

Haslett PA, Klausner JD, Makonkawkeyoon S, Moreira A, Metatratip P, Boyle B, Kunachiwa W, Maneekarn N, Vongchan P, Corral LG, Elbeik T, Shen Z, Kaplan G. Haslett PA, et al. AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1169-79. doi: 10.1089/088922299310269. AIDS Res Hum Retroviruses. 1999. PMID: 10480630 Clinical Trial.

2

Adverse reactions to thalidomide in patients infected with human immunodeficiency virus.

Haslett P, Tramontana J, Burroughs M, Hempstead M, Kaplan G. Haslett P, et al. Clin Infect Dis. 1997 Jun;24(6):1223-7. doi: 10.1086/513665. Clin Infect Dis. 1997. PMID: 9195087

3

The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus.

Haslett P, Hempstead M, Seidman C, Diakun J, Vasquez D, Freedman VH, Kaplan G. Haslett P, et al. AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):1047-54. doi: 10.1089/aid.1997.13.1047. AIDS Res Hum Retroviruses. 1997. PMID: 9264292 Clinical Trial.

4

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.

Haslett PA, Nixon DF, Shen Z, Larsson M, Cox WI, Manandhar R, Donahoe SM, Kaplan G. Haslett PA, et al. J Infect Dis. 2000 Apr;181(4):1264-72. doi: 10.1086/315381. Epub 2000 Apr 5. J Infect Dis. 2000. PMID: 10751137

5

Thalidomide for the treatment of AIDS-associated wasting.

Kaplan G, Thomas S, Fierer DS, Mulligan K, Haslett PA, Fessel WJ, Smith LG, Kook KA, Stirling D, Schambelan M. Kaplan G, et al. Among authors: haslett pa. AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1345-55. doi: 10.1089/08892220050140892. AIDS Res Hum Retroviruses. 2000. PMID: 11018854 Clinical Trial.

6

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset.

Haslett PA, Corral LG, Albert M, Kaplan G. Haslett PA, et al. J Exp Med. 1998 Jun 1;187(11):1885-92. doi: 10.1084/jem.187.11.1885. J Exp Med. 1998. PMID: 9607928 Free PMC article.

7

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.

Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G. Corral LG, et al. Among authors: haslett pa. J Immunol. 1999 Jul 1;163(1):380-6. J Immunol. 1999. PMID: 10384139

8

Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro.

Haslett PA, Hanekom WA, Muller G, Kaplan G. Haslett PA, et al. J Infect Dis. 2003 Mar 15;187(6):946-55. doi: 10.1086/368126. Epub 2003 Mar 6. J Infect Dis. 2003. PMID: 12660941

9

The immunomodulatory effects of thalidomide on human immunodeficiency virus-infected children.

Hanekom WA, Hughes J, Haslett PA, Apolles P, Ganiso V, Allin R, Goddard E, Hussey GD, Kaplan G. Hanekom WA, et al. Among authors: haslett pa. J Infect Dis. 2001 Nov 1;184(9):1192-6. doi: 10.1086/323806. Epub 2001 Sep 21. J Infect Dis. 2001. PMID: 11598844 Clinical Trial.

10

Thalidomide in toxic epidermal necrolysis.

Klausner JD, Kaplan G, Haslett PA. Klausner JD, et al. Among authors: haslett pa. Lancet. 1999 Jan 23;353(9149):324. doi: 10.1016/S0140-6736(05)74905-9. Lancet. 1999. PMID: 9929047 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page